Shorter vs standard breast radiation after lumpectomy
Part of Cancer, Skin clinical trials.
This study compares a shorter course of radiation to a standard longer course after breast-conserving surgery (lumpectomy). It’s meant to see which schedule works just as well while focusing on safety and cancer control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and age 18–70
- Your breast cancer was removed with lumpectomy, with clear (negative) margins
- Your cancer is invasive breast cancer (not only DCIS), and has no distant spread
- You have either sentinel node biopsy only or a specific axillary node surgery plan, based on results
- You can safely receive radiation after surgery (no major radiation contraindications) and can complete follow-up
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter, more intense course of daily radiation therapy (called ultra hypo-fractionation) given after lumpectomy for early-stage breast cancer. The goal is to reduce the number of treatment visits while keeping the same high level of effectiveness and safety.
This trial compares two ways of giving radiation to the breast/chest wall and nearby lymph nodes after breast surgery: a standard schedule versus a shorter “hypofractionated” schedule. It uses proton therapy and may help reduce treatment time while still controlling the cancer.
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
This trial compares a shorter radiation plan to a standard longer plan after mastectomy for people considered high risk. It may help reduce treatment time while still trying to prevent breast-cancer recurrence.
This trial compares standard radiation therapy to a shorter course (hypofractionated) for women who have had a mastectomy with implant reconstruction. The goal is to see if the shorter schedule works as well while possibly reducing side effects for the reconstructed breast.
This study compares two types of proton radiation after lumpectomy for early breast cancer. It tests whether a shorter, stronger course (ultra-hypofractionated) works as well as a slightly longer moderate course.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.